Invest Now
Products +
Pricing
Trading & Investing +
Calculators +
Support +
Learn +
IPO +
Partner
About us +
#AndekhaSach New
Login Open an account
Samco securities limited
Samco Star Rating Ads

Natco Pharma Ltd Share Price

₹ 1,416.95 -59.85 (-4.05%)

Updated on 21-12-2024 6:56 AM

Stock Rating

Pros 4

 

Cons 3

Natco Pharma Ltd Price Performance

  • Day's Low
  • ₹1,410
  • Day's High
  • ₹1,481.75
₹ 1,416.95
  • 52-w low
  • ₹755
  • 52-w high
  • ₹1,639
1,416.95
  • Day's open
    ₹1,480.50
  • Previous close
    ₹1,476.80
  • VWAP
    ₹1,444.28
  • Lower price band
    ₹1,181.45
  • Upper price band
    ₹1,772.15

Today's Market Action

The last traded share price of Natco Pharma Ltd was 1,416.95 down by -4.05% on the NSE. Its last traded stock price on BSE was 1,418.75 down by -3.92%. The total volume of shares on NSE and BSE combined was 510,349 shares. Its total combined turnover was Rs 73.73 crores.

Natco Pharma Ltd Medium and Long Term Market Action

Natco Pharma Ltd hit a 52-week high of 1,639 on 12-09-2024 and a 52-week low of 755 on 21-12-2023. The stock price of Natco Pharma Ltd is up by 4% over the last one month. It is up by 84.9% over the last one year. Don't forget to check the full stock price history in the table below.

Natco Pharma Ltd Fundamentals

  • Market Cap (Cr): 24655

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Natco Pharma Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Natco Pharma Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Natco Pharma Ltd

Data not available.

Natco Pharma Ltd FAQ's

What is Share Price of Natco Pharma Ltd?

What is the Market Cap of Natco Pharma Ltd?

What is PE Ratio of Natco Pharma Ltd?

What is PB Ratio of Natco Pharma Ltd?

What is the CAGR of Natco Pharma Ltd?

How to Buy Natco Pharma Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • High Pricing Power
    The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.03. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.38. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 231 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(21/12/2024)
Stock Valuation
Green line
94
88.89%
88.89% People are bullish about Natco Pharma Ltd
11.11%
11.11 % People are bearish about Natco Pharma Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Natco Pharma Ltd

₹ 1,416.95 -59.85 (-4.05%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon
      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91